The rising burden of antimicrobial resistance (AMR) among pathogens causing bovine mastitis has become a critical challenge for both animal health and the dairy economy of Pakistan. Excessive and inappropriate use of antibiotics has led to the emergence of resistant bacterial strains, significantly reducing treatment efficacy and increasing economic losses in the dairy sector. Moreover, currently available commercial vaccines fail to provide adequate protection, as they are not tailored to local circulating strains. This study aims to develop a chimeric, strain-specific vaccine targeting mastitis-causing bacterial pathogens prevalent in Sindh, Pakistan. Milk samples were collected from dairy farms across the region, and mastitis-associated bacteria were isolated using CHROMagar™ Mastitis medium. Identification was performed through 16S rRNA gene sequencing. Following this, selected isolates will be subjected to whole genome sequencing to identify potential antigenic targets. Subsequently, an immunoinformatics-based approach will be employed to predict B-cell epitopes and design a multi-epitope chimeric vaccine candidate. In silico immune simulation will be conducted to evaluate the immunogenic potential of the designed construct. Preliminary findings indicate that Staphylococcus aureus and Escherichia coli are the most prevalent mastitis-associated pathogens, followed by Klebsiella pneumoniae and Streptococcus dysgalactiae. Additionally, less commonly reported species, including Staphylococcus chromogenes, Staphylococcus simulans, Staphylococcus sciuri, Staphylococcus saprophyticus, and Staphylococcus haemolyticus, were also identified, highlighting the diverse microbial landscape of mastitis in the region. This study is expected to provide a foundation for the development of a region-specific chimeric vaccine and offers a promising alternative to conventional antibiotic-based control strategies.